Chesley Leslin

Chesley Leslin possesses extensive expertise in bioinformatics and computational biology, currently serving as Chief Scientific Officer at Boston Lighthouse Innovations, where a genomics software solution supports next-generation sequencing and clinical result reporting for cancer patient tumor samples. In addition, Chesley lectures in bioinformatics at Northeastern University and co-founded Standard Molecular, Inc., where groundbreaking software for cancer therapy eligibility was developed. Previous roles include Group Leader at Brigham and Women's Hospital, Head of Bioinformatics at IntelligentMDx, and contributions as a bioinformatician at both Epstein Lab and NovoBiotic Pharmaceuticals. Educational credentials include a Ph.D. in Bioinformatics/Computational Biology from Northeastern University and a Master of Science in Bioinformatics from Northern Illinois University.